Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898820 · ClinicalTrials.gov registry record
Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 80
- Enrollment target
NCT00898820: Completed study, sponsored by Mayo Clinic.
NCT00898820 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898820 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood in the laboratory from patients receiving pemetrexed disodium may help doctors learn more about the effects of pemetrexed disodium on cells. It may also help doctors understand how well patients respond to treatment. PURPOSE: This laboratory study is looking at blood samples from patients with stage III or stage IV non-small cell lung cancer enrolled in clinical trial MCCRC-RC0524 to determine the effect of pemetrexed disodium on cells.
Interventions
- GENETIC gene expression analysis
- GENETIC protein expression analysis
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-12 |
What the finished NCT00898820 record still lists
NCT00898820 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which gene expression analysis is the first listed.
NCT00898820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898820 about?
NCT00898820 is a clinical study titled "Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524". RATIONALE: Studying samples of blood in the laboratory from patients receiving pemetrexed disodium may help doctors learn more about the effects of pemetrexed disodium on cells. It may also help doctors understand how well patients respond to treatment. PURPOSE: This laboratory study is looking at ...
What is the current status of trial NCT00898820?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2006-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00898820?
The interventions under investigation include: gene expression analysis (GENETIC), protein expression analysis (GENETIC), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT00898820?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia